Renaissance Technologies’s Baird Medical Investment Holdings BDMD Stock Holding History
Bought
Maintained
Sold
Other funds holding BDMD
GSC
Renaissance Technologies's BDMD Position: Q3 2026 in Review
Renaissance Technologies increased its Baird Medical Investment Holdings (BDMD) stake by 31% in Q3 2026, buying an estimated $18.2K and bringing the position to 72,400 shares worth $56.5K. The position accounts for ﹤0.01% of the portfolio, ranked #3076.
Renaissance Technologies first reported a position in BDMD in Q2 2026 and has held it in 2 quarters since. The position peaked at $63.7K in Q2 2026. 7 funds tracked by Wall St. Rank hold BDMD as of Q3 2026.
- Renaissance Technologies held 72,400 shares of Baird Medical Investment Holdings worth $56.5K as of Q3 2026.
- Renaissance Technologies bought 17,029 Baird Medical Investment Holdings shares in Q3 2026, an estimated $18.2K.
- Baird Medical Investment Holdings made up ﹤0.01% of Renaissance Technologies's portfolio in Q3 2026, its #3076 holding.
- Renaissance Technologies first reported a position in Baird Medical Investment Holdings in Q2 2026 and has held it in 2 quarters since.
- Renaissance Technologies's Baird Medical Investment Holdings position peaked at $63.7K in Q2 2026.
- 7 funds tracked by Wall St. Rank held Baird Medical Investment Holdings as of Q3 2026.
Based on Renaissance Technologies's 13F filing for Q3 2026, filed 12 Nov 2026.